Summary:The efficacy of a superficial temporal artery (STA)-middle cerebral artery (MCA) anastomosis for patients with poor cerebral blood flow (CBF) and severe decrease of cerebral vascular reserve (CVR) has been recently proved in a Japanese EC-IC bypass trial study. However, we have little clinical knowledge or evidence regarding how to increase CBF or how to evade ischemic risk when performing this surgery. We examined the size and the number of the donor arteries and the location of the recipient artery to retrospectively determine the difference of increase on CBF and CVR by their methods.The objects were 34 patients with preoperative misery perfusion of low rCBF and poor rCVR. Both were evaluated preoperatively, immediately after operation, and at least 3 weeks after operation with N-isopropyl-p-[123 I] iodoamphetamine. The patients were divided into groups based on the number of the donor arteries or the location of the recipient artery and statistically compared.Postoperative rCVRs increased dramatically from preoperative rCVRs, compared with a small increase of rCBF. Single bypass showed an increase of rCBF and rCVR similar to that of double bypass. Selection of the recipient artery in the sylvian fissure showed significantly more increase of rCVR.Double bypass with selection of the larger recipient artery was most effective for improving misery perfusion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.